Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
657 NT-I7, a long-acting IL-7, plus pembrolizumab favors CD8 T-cell infiltration in liver metastases of heavily pre-treated, immunologically cold, MSS-colorectal and pancreatic cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.